Search
for
Sort by
Research 331–360 of 1000+
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
- Bempikibart shows its potential for hair regrowth in alopecia areata
- The Relationship Between ABO And Rh Blood Groups With Alopecia Areata
- Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
- Intra-Individual Comparative Study of Methotrexate versus Triamcinolone Acetonide Delivered via Microneedling for Recalcitrant Alopecia Areata
- COMPARATIVE EFFICACY OF TOPICAL CLOBETASOL PROPIONATE 0.05% OINTMENT AND TOPICAL TACROLIMUS 0.1% OINTMENT IN THE TREATMENT OF ALOPECIA AREATA
- Serum level of calprotectin as a new inflammatory marker in patients with alopacia areata
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- Comparative Efficacy of Microneedling with and without Topical Vitamin D3 in Localized Alopecia areata
- Comparison of Efficacy of Platelet Rich Plasma with Intralesional Triamcinolone in the treatment of Alopecia Areata
- Comparative Efficacy of Topical Calcipotriol, Intralesional Autologous Platelet-Rich Plasma Injection, and Combined Topical Calcipotriol with Intralesional Autologous Platelet-Rich Plasma Injection on Patients with Alopecia Areata
- Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program
- Scaffolds for epidermal tissue engineering
- Table 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- Supplementary file 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Salt-losing tubulopathy and chronic dermatitis
- Effect of Selamectin spot-on against the Lynxacarus radovskyi infestation in cats
- Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Quantifying Alopecia Areata via Texture Analysis to Automate the SALT Score Computation
- Rat steroid 5α-reductase kinetic characteristics: Extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- 530 A clinical comparison of photobiomodulation devices for the treatment of alopecia in all skin types
- 10.51847/ubmwCM2
- ALOPECIA AREATA MANAGED SOLELY THROUGH INTERNAL AYURVEDIC INTERVENTION: A CASE REPORT
- ALOPECIA AREATA MANAGED SOLELY THROUGH INTERNAL AYURVEDIC INTERVENTION: A CASE REPORT